vs

Side-by-side financial comparison of Outset Medical, Inc. (OM) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.

Outset Medical, Inc. is the larger business by last-quarter revenue ($28.9M vs $24.0M, roughly 1.2× SIFCO INDUSTRIES INC). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -67.5%, a 75.0% gap on every dollar of revenue. On growth, SIFCO INDUSTRIES INC posted the faster year-over-year revenue change (14.8% vs -2.0%). SIFCO INDUSTRIES INC produced more free cash flow last quarter ($8.0M vs $-9.7M). Over the past eight quarters, SIFCO INDUSTRIES INC's revenue compounded faster (8.1% CAGR vs 1.2%).

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.

OM vs SIF — Head-to-Head

Bigger by revenue
OM
OM
1.2× larger
OM
$28.9M
$24.0M
SIF
Growing faster (revenue YoY)
SIF
SIF
+16.8% gap
SIF
14.8%
-2.0%
OM
Higher net margin
SIF
SIF
75.0% more per $
SIF
7.5%
-67.5%
OM
More free cash flow
SIF
SIF
$17.7M more FCF
SIF
$8.0M
$-9.7M
OM
Faster 2-yr revenue CAGR
SIF
SIF
Annualised
SIF
8.1%
1.2%
OM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OM
OM
SIF
SIF
Revenue
$28.9M
$24.0M
Net Profit
$-19.5M
$1.8M
Gross Margin
42.4%
21.6%
Operating Margin
-61.1%
10.7%
Net Margin
-67.5%
7.5%
Revenue YoY
-2.0%
14.8%
Net Profit YoY
24.0%
177.3%
EPS (diluted)
$0.33
$0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OM
OM
SIF
SIF
Q4 25
$28.9M
$24.0M
Q3 25
$29.4M
$22.8M
Q2 25
$31.4M
$22.1M
Q1 25
$29.8M
$19.0M
Q4 24
$29.5M
$20.9M
Q3 24
$28.7M
$21.7M
Q2 24
$27.4M
$22.0M
Q1 24
$28.2M
$20.5M
Net Profit
OM
OM
SIF
SIF
Q4 25
$-19.5M
$1.8M
Q3 25
$-17.8M
$-429.0K
Q2 25
$-18.5M
$3.4M
Q1 25
$-25.8M
$-1.4M
Q4 24
$-25.6M
$-2.3M
Q3 24
$-27.9M
$-443.0K
Q2 24
$-34.5M
$72.0K
Q1 24
$-39.9M
$-1.6M
Gross Margin
OM
OM
SIF
SIF
Q4 25
42.4%
21.6%
Q3 25
39.4%
9.6%
Q2 25
37.8%
26.7%
Q1 25
37.2%
8.3%
Q4 24
36.5%
4.4%
Q3 24
34.3%
10.7%
Q2 24
35.7%
12.3%
Q1 24
29.2%
7.3%
Operating Margin
OM
OM
SIF
SIF
Q4 25
-61.1%
10.7%
Q3 25
-53.7%
-1.7%
Q2 25
-53.7%
14.8%
Q1 25
-55.1%
-4.1%
Q4 24
-74.2%
-9.2%
Q3 24
-83.2%
-1.5%
Q2 24
-112.3%
0.7%
Q1 24
-131.0%
-6.5%
Net Margin
OM
OM
SIF
SIF
Q4 25
-67.5%
7.5%
Q3 25
-60.6%
-1.9%
Q2 25
-59.0%
15.4%
Q1 25
-86.7%
-7.3%
Q4 24
-87.0%
-11.1%
Q3 24
-97.5%
-2.0%
Q2 24
-125.8%
0.3%
Q1 24
-141.8%
-7.8%
EPS (diluted)
OM
OM
SIF
SIF
Q4 25
$0.33
$0.29
Q3 25
$-1.00
$-0.07
Q2 25
$-1.04
$0.56
Q1 25
$-3.66
$-0.23
Q4 24
$-7.21
$-0.38
Q3 24
$-8.02
$-0.07
Q2 24
$-9.96
$0.01
Q1 24
$-11.77
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OM
OM
SIF
SIF
Cash + ST InvestmentsLiquidity on hand
$168.9M
$1.1M
Total DebtLower is stronger
$96.2M
$39.0K
Stockholders' EquityBook value
$127.0M
$38.7M
Total Assets
$264.5M
$74.9M
Debt / EquityLower = less leverage
0.76×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OM
OM
SIF
SIF
Q4 25
$168.9M
$1.1M
Q3 25
$178.6M
$491.0K
Q2 25
$184.1M
$2.0M
Q1 25
$189.0M
$1.9M
Q4 24
$158.7M
$3.1M
Q3 24
$175.6M
$1.7M
Q2 24
$194.8M
$3.4M
Q1 24
$226.9M
$2.5M
Total Debt
OM
OM
SIF
SIF
Q4 25
$96.2M
$39.0K
Q3 25
$51.0K
Q2 25
Q1 25
Q4 24
$197.4M
Q3 24
$0
Q2 24
$3.6M
Q1 24
$4.1M
Stockholders' Equity
OM
OM
SIF
SIF
Q4 25
$127.0M
$38.7M
Q3 25
$142.4M
$36.9M
Q2 25
$154.8M
$35.8M
Q1 25
$169.9M
$32.4M
Q4 24
$26.8M
$33.7M
Q3 24
$47.8M
$30.4M
Q2 24
$68.6M
$29.8M
Q1 24
$93.2M
$29.7M
Total Assets
OM
OM
SIF
SIF
Q4 25
$264.5M
$74.9M
Q3 25
$277.3M
$73.4M
Q2 25
$288.8M
$77.3M
Q1 25
$301.2M
$78.8M
Q4 24
$275.8M
$81.0M
Q3 24
$292.9M
$104.6M
Q2 24
$314.5M
$106.3M
Q1 24
$346.2M
$104.2M
Debt / Equity
OM
OM
SIF
SIF
Q4 25
0.76×
0.00×
Q3 25
0.00×
Q2 25
Q1 25
Q4 24
7.36×
Q3 24
0.00×
Q2 24
0.12×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OM
OM
SIF
SIF
Operating Cash FlowLast quarter
$-9.5M
$8.1M
Free Cash FlowOCF − Capex
$-9.7M
$8.0M
FCF MarginFCF / Revenue
-33.7%
33.3%
Capex IntensityCapex / Revenue
0.8%
0.4%
Cash ConversionOCF / Net Profit
4.51×
TTM Free Cash FlowTrailing 4 quarters
$-47.1M
$11.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OM
OM
SIF
SIF
Q4 25
$-9.5M
$8.1M
Q3 25
$-6.3M
$726.0K
Q2 25
$-4.8M
$371.0K
Q1 25
$-25.7M
$2.8M
Q4 24
$-16.5M
$-3.8M
Q3 24
$-20.6M
$857.0K
Q2 24
$-33.3M
$382.0K
Q1 24
$-45.9M
$-3.2M
Free Cash Flow
OM
OM
SIF
SIF
Q4 25
$-9.7M
$8.0M
Q3 25
$-6.5M
$566.0K
Q2 25
$-5.1M
$310.0K
Q1 25
$-25.8M
$2.7M
Q4 24
$-16.5M
$-3.9M
Q3 24
$-21.0M
$580.0K
Q2 24
$-33.5M
$-175.0K
Q1 24
$-46.3M
$-3.9M
FCF Margin
OM
OM
SIF
SIF
Q4 25
-33.7%
33.3%
Q3 25
-22.0%
2.5%
Q2 25
-16.3%
1.4%
Q1 25
-86.7%
14.1%
Q4 24
-56.1%
-18.8%
Q3 24
-73.1%
2.7%
Q2 24
-122.2%
-0.8%
Q1 24
-164.3%
-18.9%
Capex Intensity
OM
OM
SIF
SIF
Q4 25
0.8%
0.4%
Q3 25
0.5%
0.7%
Q2 25
0.9%
0.3%
Q1 25
0.4%
0.8%
Q4 24
0.1%
0.5%
Q3 24
1.4%
1.3%
Q2 24
0.4%
2.5%
Q1 24
1.3%
3.3%
Cash Conversion
OM
OM
SIF
SIF
Q4 25
4.51×
Q3 25
Q2 25
0.11×
Q1 25
Q4 24
Q3 24
Q2 24
5.31×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

SIF
SIF

Fixed Wing Aircraft Revenue$10.5M44%
Commercial Revenue$8.7M36%
Commercial Product And Other Revenue$2.8M12%
Commercial Space$1.1M5%
Other$840.0K4%

Related Comparisons